Essential Partners LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History

Essential Partners LLC’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37K	Sell
2025 Q4	$31.6K	Sell
2025 Q3	$38.3K	Sell
2025 Q2	$58.6K	Buy